The wave of AI is accelerating the transformation of the global pharmaceutical industry. AI startup therapiAI announced today (Feb 9) the completion of a Phase 1 AI Proof of Concept (POC) with Panlabs, a world-class leader in biotechnology. Focusing on
Continue Reading
therapiAI, a leading AI pharmaceutical company, announced today the launch of the world’s first AI Agent dedicated to Antibody-Drug Conjugates (ADCs). This technology significantly compresses the traditional 2-3 year R&D exploration phase. By following the AI Agent’s recommendations, researchers can
Continue Reading
TherapiAI Partners with 100+ Global Pharma Firms at Tokyo Expo to Launch International Expansion Enhancing R&D Efficiency and Compliance Management for Pharmaceutical Companies with an AI Agent Decision Platform. Deepening Taiwan-Japan Collaboration to Establish the APAC Market as the Infrastructure
Continue Reading
INTERPHEX Week Osaka is one of Japan’s leading pharmaceutical exhibitions and one of the largest pharma R&D and manufacturing technology shows in Asia. It is held annually at INTEX Osaka, organized by RX Japan Ltd., with support from major pharmaceutical
Continue Reading
As Regenerative Medicine emerges as the next frontier of the global biotech industry, Japan has cemented its status as a pivotal hub in Asia and beyond. This leadership is built upon an advanced regulatory framework and unparalleled manufacturing craftsmanship.From the
Continue Reading
A Great Success for AKOUSIST (now therapiAI) at MedTec Japan! During the exhibition, we unveiled three AI Agents specifically tailored for pharmaceutical CDMOs. The showcase attracted significant attention from numerous R&D professionals and regulatory experts, facilitating in-depth technical exchanges on
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
